Page last updated: 2024-08-23

nigericin and fluticasone

nigericin has been researched along with fluticasone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cipollina, C; Di Sano, C; Di Vincenzo, S; Gjomarkaj, M; Pace, E; Siena, L	1

Other Studies

1 other study(ies) available for nigericin and fluticasone

Article	Year
17-oxo-DHA displays additive anti-inflammatory effects with fluticasone propionate and inhibits the NLRP3 inflammasome. Scientific reports, 2016, 11-24, Volume: 6 Topics: Aged; Anti-Inflammatory Agents; Case-Control Studies; Caspase 1; Cell Line; Cell Separation; Docosahexaenoic Acids; Enzyme Activation; Female; Fluticasone; Humans; Inflammasomes; Interleukin-1beta; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Mitochondria; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Proteolysis; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Receptors, Glucocorticoid; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Necrosis Factor-alpha	2016

Article

Year

17-oxo-DHA displays additive anti-inflammatory effects with fluticasone propionate and inhibits the NLRP3 inflammasome.

Scientific reports, 2016, 11-24, Volume: 6

Topics: Aged; Anti-Inflammatory Agents; Case-Control Studies; Caspase 1; Cell Line; Cell Separation; Docosahexaenoic Acids; Enzyme Activation; Female; Fluticasone; Humans; Inflammasomes; Interleukin-1beta; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Mitochondria; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Proteolysis; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Receptors, Glucocorticoid; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Necrosis Factor-alpha

2016